Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

EGLN2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart diseases

US Patent 8329167 · Granted Dec 11, 2012

Estimated economic value: $15,255,000

Assignee

Inventors

View full patent text on Google Patents →